Takara Bio Signs Exclusive License Agreement with Otsuka for the Investigational Cancer Treatment HF10, an Oncolytic Virus

Takara Bio Signs Exclusive License Agreement with Otsuka for the Investigational Cancer Treatment HF10, an Oncolytic Virus Kusatsu/Shiga, Japan — December 15, 2016 — Takara Bio Inc. (Takara) announced today that it has entered into an exclusive license agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) for co-development and commercialization in Japan of the oncolytic virus... Read more

Takara Bio USA Holdings, Inc. and Rubicon Genomics Announce Merger Agreement

Takara Bio USA Holdings, Inc. and Rubicon Genomics Announce Merger Agreement Mountain View, CA and Ann Arbor, MI —December 15, 2016—Takara Bio USA Holdings, Inc. (“TBUSH”) and Rubicon Genomics, Inc. (“Rubicon”), today announced the signing of a merger agreement pursuant to which TBUSH will acquire Rubicon, a privately-owned company headquartered in Ann Arbor, Michigan. Rubicon... Read more

Press Release: Tailor-made services for retailers: METTLER TOLEDO presents new Service Competence Brochure

Within the framework of its professional services, METTLER TOLEDO also helps its retail customers by adapting the weighing technology to their individual needs. This enables retailers to differentiate themselves from their competitors and supports targeted promotional activities. Such adaptations can include tailor-made layouts for the operator screens on scales and conceptualization of digital signage campaigns.... Read more

Time-Lapse Revealing Surprisingly “Elegant” Water Patterns of Starfish Larva Wins Nikon Small World In Motion Competition

MELVILLE, N.Y., Dec. 14, 2016 (GLOBE NEWSWIRE) — Nikon Instruments Inc. today unveiled the winners of the sixth annual Nikon Small World in Motion Photomicrography Competition, awarding First Place to William Gilpin of Stanford University for his video depicting an eight-week-old starfish larva churning the water around its body as it searches for food. Gilpin... Read more

Reliable and reproducible flow cytometry results

Miltenyi Biotec introduces the largest portfolio of recombinant antibodies optimized for flow cytometry – REAfinity™ Antibodies  BERGISCH GLADBACH, December 8, 2016 – Miltenyi Biotec has expanded its antibody portfolio and now offers more than 500 new recombinantly engineered antibodies – the REAfinity™ Antibodies optimized for flow cytometry. These antibodies display considerable advantages over conventional monoclonal antibodies... Read more